85 related articles for article (PubMed ID: 11820611)
21. Synthesis of new 2-galactosylthiazolidine-4-carboxylic acid amides. Antitumor evaluation against melanoma and breast cancer cells.
Serra AC; Rocha Gonsalves AM; Laranjo M; Abrantes AM; Gonçalves AC; Sarmento-Ribeiro AB; Botelho MF
Eur J Med Chem; 2012 Jul; 53():398-402. PubMed ID: 22560315
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
[TBL] [Abstract][Full Text] [Related]
23. Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.
Fisher GR; Patterson LH
Cancer Chemother Pharmacol; 1992; 30(6):451-8. PubMed ID: 1394801
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF
Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945
[TBL] [Abstract][Full Text] [Related]
25. Pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates. Synthesis, DNA binding and cytotoxicity.
Kamal A; Ramu R; Khanna GB; Saxena AK; Shanmugavel M; Pandita RM
Bioorg Med Chem Lett; 2004 Oct; 14(19):4907-9. PubMed ID: 15341949
[TBL] [Abstract][Full Text] [Related]
26. Antitumor agents--CLXVII. Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-epoxypropylamino)-9,10-anthracenedione, and of related compounds.
Johnson MG; Kiyokawa H; Tani S; Koyama J; Morris-Natschke SL; Mauger A; Bowers-Daines MM; Lange BC; Lee KH
Bioorg Med Chem; 1997 Aug; 5(8):1469-79. PubMed ID: 9313853
[TBL] [Abstract][Full Text] [Related]
27. β-Nitro substituted carboxylic acids and their cytotoxicity.
Csuk R; Heller L; Siewert B; Gutnov A; Seidelmann O; Wendisch V
Bioorg Med Chem Lett; 2014 Aug; 24(16):4011-3. PubMed ID: 25001484
[TBL] [Abstract][Full Text] [Related]
28. Small-molecule based delivery systems for alkylating antineoplastic compounds.
Bielawski K; Bielawska A
ChemMedChem; 2008 Apr; 3(4):536-42. PubMed ID: 18157855
[TBL] [Abstract][Full Text] [Related]
29. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives.
Nebois P; do Nascimento SC; Boitard M; Bartoli MH; Fillion H
Pharmazie; 1994 Nov; 49(11):819-21. PubMed ID: 7838868
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro cytotoxicity of 3-substituted-1,8-diazaanthraquinones produced by Lewis-acid catalyzed hetero Diels-Alder reaction.
Lee H; Lee SI; Yang SI
Bioorg Med Chem Lett; 1998 Nov; 8(21):2991-4. PubMed ID: 9873661
[TBL] [Abstract][Full Text] [Related]
34. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic and antiestrogenic effects of raloxifene on collagen metabolism in breast cancer MCF-7 cells.
Wołczynski S; Surazyński A; Swiatecka J; Pałka J
Gynecol Endocrinol; 2001 Jun; 15(3):225-33. PubMed ID: 11447735
[TBL] [Abstract][Full Text] [Related]
36. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 9,10-anthraquinone monoalkylaminoalkylhydrazones as potential antitumor drugs.
Antonini I; Polucci P; Cola D; Palmieri G; Martelli S; Bontemps-Gracz M
Farmaco; 1993 Dec; 48(12):1641-8. PubMed ID: 8135988
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antituberculosis activity of novel mefloquine-isoxazole carboxylic esters as prodrugs.
Mao J; Yuan H; Wang Y; Wan B; Pak D; He R; Franzblau SG
Bioorg Med Chem Lett; 2010 Feb; 20(3):1263-8. PubMed ID: 20022500
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel nucleoside analogue phosphorothioamidate prodrugs and in vitro anticancer evaluation against RKO human colon carcinoma cells.
Liu W; Zhang L; Zhou H; Yang C; Miao Z; Zhao Y
Nucleosides Nucleotides Nucleic Acids; 2013; 32(4):161-73. PubMed ID: 24001190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
